These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 5427447)

  • 21. [Raynaud's syndrome--main symptom of progressive systemic sclerosis (sclerodermia)].
    Krull P; Alexander K; Fabel H; Ostertag H; Wagner HH; Deicher H
    Med Klin; 1972 Mar; 67(10):332-7. PubMed ID: 5022240
    [No Abstract]   [Full Text] [Related]  

  • 22. Progressive systemic sclerosis. "Something old, something new, something borrowed, something blue".
    Martin D; Woeber KA; Smith LH
    Calif Med; 1973 Aug; 119(2):35-42. PubMed ID: 4726949
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hemodialysis and kidney transplantation for renal failure from scleroderma.
    Richardson JA
    Arthritis Rheum; 1973; 16(2):265-71. PubMed ID: 4577393
    [No Abstract]   [Full Text] [Related]  

  • 24. [M scleroderma (with systemic progressive sclerosis) associated with clinical and biological signs of dermatomyositis and lupus erythematosus].
    Grupper C; Durepaire RM; Eisenmann D; Briche R
    Bull Soc Fr Dermatol Syphiligr; 1972; 79(3):219-20. PubMed ID: 4642837
    [No Abstract]   [Full Text] [Related]  

  • 25. Three cases of osteonecrosis of the lunate bone of the wrist in scleroderma.
    Matsumoto AK; Moore R; Alli P; Wigley FM
    Clin Exp Rheumatol; 1999; 17(6):730-2. PubMed ID: 10609074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal manifestations of progressive systemic scleroderma based on a review of 364 cases.
    Poirier TJ; Rankin GB
    Am J Gastroenterol; 1972 Jul; 58(1):30-44. PubMed ID: 4537959
    [No Abstract]   [Full Text] [Related]  

  • 27. Scleroderma. 2. Incidence of systemic disturbance and assessment of possible aetiological factors.
    Barnett AJ; Coventry DA
    Med J Aust; 1969 May; 1(20):1040-7. PubMed ID: 4891934
    [No Abstract]   [Full Text] [Related]  

  • 28. Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients.
    Poormoghim H; Lucas M; Fertig N; Medsger TA
    Arthritis Rheum; 2000 Feb; 43(2):444-51. PubMed ID: 10693887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localized scleroderma in childhood is not just a skin disease.
    Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
    Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Systemic sclerosis: a multisystem disease].
    Berrevoets MA; Markhorst J; Meek I; van Ede AE; Vonk MC
    Ned Tijdschr Geneeskd; 2014; 158():A7703. PubMed ID: 25052356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome.
    Varga J; Heiman-Patterson TD; Emery DL; Griffin R; Lally EV; Uitto JJ; Jimenez SA
    Semin Arthritis Rheum; 1990 Jun; 19(6):313-28. PubMed ID: 2164712
    [No Abstract]   [Full Text] [Related]  

  • 32. The spectrum of scleroderma (II).
    LeRoy EC; Lomeo R
    Hosp Pract (Off Ed); 1989 Nov; 24(11):65-8, 69-72, 75-6 passim. PubMed ID: 2509504
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical manifestations of systemic sclerosis.
    Steen VD
    Semin Cutan Med Surg; 1998 Mar; 17(1):48-54. PubMed ID: 9512107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Possible adverse effect of phenoxybenzamine therapy in a patient with progressive systemic sclerosis.
    Parker LP; Hahn BH; Osterland CK
    Arthritis Rheum; 1972; 15(5):535-9. PubMed ID: 4634806
    [No Abstract]   [Full Text] [Related]  

  • 35. Scleroderma and related disorders: therapeutic aspects.
    Denton CP; Black CM
    Baillieres Best Pract Res Clin Rheumatol; 2000 Mar; 14(1):17-35. PubMed ID: 10882212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Systemic scleroderma].
    Saporta L
    Rev Prat; 1975 May; 25(25):1937-42. PubMed ID: 1135583
    [No Abstract]   [Full Text] [Related]  

  • 37. [Articular manifestations in systemic progressive sclerosis].
    Messina OD; Maldonado Cocco JA; Nasswetter GG; García Morteo OM
    Rev Clin Esp; 1985 Apr; 176(7):354-5. PubMed ID: 4011982
    [No Abstract]   [Full Text] [Related]  

  • 38. Sclerodermatomyositis with megacolon, small-bowel involvement and impaired lung function.
    Srinivas V
    Proc R Soc Med; 1976 Apr; 69(4):263-4. PubMed ID: 1265031
    [No Abstract]   [Full Text] [Related]  

  • 39. Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis.
    Nishibu A; Sakai E; Oyama N; Yamamoto T
    Australas J Dermatol; 2012 May; 53(2):e32-3. PubMed ID: 22571581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features.
    Valentini G; Cuomo G; Abignano G; Petrillo A; Vettori S; Capasso A; Cozzolino D; Del Genio G; Santoriello C
    Rheumatology (Oxford); 2011 Feb; 50(2):317-23. PubMed ID: 20562195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.